April 2, 2007 (Press Release) --
India: Pharmaceutical and Biotechnology Opportunities
India is an increasingly attractive destination for R&D activities in the pharmaceutical and biotechnology industry. Being an emerging market, companies face a number of unique hurdles before entering this lucrative region.
The report provides an overview of the Indian pharma and biotech market, and answers the following key questions:
Who are the key players in the Indian pharmaceutical market?
How has the Indian regulatory environment changed?
What R&D collaborative opportunities are available?
How can companies engage with India for collaboration?
What are the leading R&D companies in India doing in collaborative R&D?
Readers will gain an analysis of the regulatory environment, insights into collaborative opportunities and detailed information on the key companies, clusters and government initiatives.
For more information kindly visit
http://www.bharatbook.com/businessreports/India_Pharmaceutical_and_Biotechnology_Opportunities.html
India is an increasingly attractive destination for R&D activities in the pharmaceutical and biotechnology industry. Being an emerging market, companies face a number of unique hurdles before entering this lucrative region.
The report provides an overview of the Indian pharma and biotech market, and answers the following key questions:
Who are the key players in the Indian pharmaceutical market?
How has the Indian regulatory environment changed?
What R&D collaborative opportunities are available?
How can companies engage with India for collaboration?
What are the leading R&D companies in India doing in collaborative R&D?
Readers will gain an analysis of the regulatory environment, insights into collaborative opportunities and detailed information on the key companies, clusters and government initiatives.
For more information kindly visit
http://www.bharatbook.com/businessreports/India_Pharmaceutical_and_Biotechnology_Opportunities.html

India is an increasingly attractive destination for R&D activities in the pharmaceutical and biotechnology industry.
Email
Print
SPAM




